Association between multimorbidity and mortality in a cohort of patients admitted to hospital with COVID-19 in Scotland

Abstract

Objectives We investigated the association between multimorbidity among patients hospitalised with COVID-19 and their subsequent risk of mortality. We also explored the interaction between the presence of multimorbidity and the requirement for an individual to shield due to the presence of specific conditions and its association with mortality. Design We created a cohort of patients hospitalised in Scotland due to COVID-19 during the first wave (between 28 February 2020 and 22 September 2020) of the pandemic. We identified the level of multimorbidity for the patient on admission and used logistic regression to analyse the association between multimorbidity and risk of mortality among patients hospitalised with COVID-19. Setting Scotland, UK. Participants Patients hospitalised due to COVID-19. Main outcome measures Mortality as recorded on National Records of Scotland death certificate and being coded for COVID-19 on the death certificate or death within 28 days of a positive COVID-19 test. Results Almost 58% of patients admitted to the hospital due to COVID-19 had multimorbidity. Adjusting for confounding factors of age, sex, social class and presence in the shielding group, multimorbidity was significantly associated with mortality (adjusted odds ratio 1.48, 95%CI 1.26–1.75). The presence of multimorbidity and presence in the shielding patients list were independently associated with mortality but there was no multiplicative effect of having both (adjusted odds ratio 0.91, 95%CI 0.64–1.29). Conclusions Multimorbidity is an independent risk factor of mortality among individuals who were hospitalised due to COVID-19. Individuals with multimorbidity could be prioritised when making preventive policies, for example, by expanding shielding advice to this group and prioritising them for vaccination.

Epidemiology of SARS-CoV-2 during the first three waves in Scotland: a national record linkage study

“…Those missing information of SIMD were excluded. For all three waves, and in agreement with previous studies, 18 compared with COVID-19 survived cases, male sex, older age, increased levels of deprivation and various comorbidities were all associated with significantly increased odds of a COVID-19 death (table 3; figure 2). Comorbidities including chronic kidney disease (CKD), neurological disease, diabetes, chronic obstructive pulmonary disease (COPD) and cancer were strongly associated with a COVID-19 death across Original research all waves.…”

Trends in COVID-19 hospital outcomes in England before and after vaccine introduction, a cohort study

“…It is now well established that a segment of the population who acquire severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the virus responsible for coronavirus disease 2019 (COVID- 19), in the community will require hospitalisation, potential escalation to intensive care facilities, and may die in hospital or soon after discharge. COVID-19 has been shown to disproportionately impact older people and those with multiple co-morbidities, compared to younger, healthier individuals, and there is considerable evidence that these factors heavily influence prognosis following hospital admission for COVID-19 [1][2][3][4] .…”

Development and validation of an early warning model for hospitalized COVID-19 patients: a multi-center retrospective cohort study

“…This method assumes normally distributed predictors and may have introduced bias when missingness not at random was present [40]. While our study contains a large set of demographical and physiological measurements, several potentially relevant predictors (such as multimorbidity, frailty or pre-pandemic cognitive function [41][42][43]) were not available in our dataset. Such predictors could potentially improve the performance of predictive models.…”